Brand Awareness

Report Finds That Use of Remote Health Has Grown Significantly

A recent survey conducted in the second quarter of this year by Parks Associates has found that more than one-half of broadband households own an internet-enabled fitness or health device that records biometric data, with another two-thirds revealing that they have undergone remote health consultation. The survey, which involved 5,000 broadband households in the United States was conducted by Parks Associates, a market research and consulting firm that specializes in emerging consumer technology products.

Parks Associates senior analyst Kristen Hanich stated that the overall familiarity with telehealth had assisted in driving the connected health device market. Hanich noted that there was a strong link between wanting the benefits of connected health, such as remote monitoring and remote diagnostics, and the familiarity with telehealth.

The firm recently hosted a virtual session on the influence of artificial intelligence on connected health. It featured Musical Health Technologies chief clinical officer Andy Tubman and the founder and CEO of b.well Connected Health Kristen Valdes, who participated in an executive Q&A session. In addition to this, there was an interactive panel comprised of Biofourmiss COO Jaydev Thakkar, JVION chief product officer John Showalter, Valencell co-founder and president Dr. Steven LeBoeuf, Nuance general manager of diagnostics and senior vice president Karen Holzberger, Optum technology fellow and senior vice president Kerrie Holley and AHA Health’s chief commercial officer Jeff Cutler.

Valdes explained that precision engagement and artificial intelligence were transforming the lives of patients into connected consumers who were taking control of their health records. She added that acquiring a 360-degree view into the health journey of every consumer was now a requirement in value-based care.

On the other hand, Holzberger stated that delivering the benefits of connected health needed a holistic view on how to use artificial intelligence and data in order to enhance patient outcomes and healthcare experiences. Holzberger also noted that the Connected Health Summit was a good opportunity to explore how various approaches would allow pharmaceutical and medical device developers, artificial intelligence, payers, health systems and providers to collaborate in actualizing personalized, precision medicine.

Additionally, Showalter stated that it was important to understand patient vulnerability as virtual care models were evolving. He explained that this included vulnerabilities such as connectedness, social supports, health literacy, activity level and lifestyle choices, noting that artificial intelligence not only brought all these pieces together but also revealed any factors that would enhance a patient’s health outcome if they were addressed.

With companies such as RYAH Group Inc. (CSE: RYAH) investing in availing technologies that facilitate the switch to telehealth, it may not be long before virtual health becomes as commonplace as in-person visits to healthcare facilities.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://ibn.fm/RYAH

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Soligenix Inc. (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma

Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the…

8 hours ago

Sapu Nano Reveals the Initial In-Human Clinical Trial of Sapu-003, Intravenous Everolimus (Afinitor(R)) at Australian Translational Breast Cancer Symposium

The company revealed the trial at the Australia Translational Breast Cancer Research Symposium (“ATBCR”) Sapu-003…

9 hours ago

How Rural Health Care is Being Impacted by the Federal Funding Landscape

Approximately 20% of people in the U.S. live in a rural area, and they face…

3 days ago

$37.5M Grant Announced to Boost Management of Infectious Diseases in the US

On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant…

4 days ago

What Patients Need to Know About the Remission Rate of Glioblastomas

Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer.…

6 days ago

Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability

Thermostable vaccine technology is considered a significant unmet need in epidemic preparedness. Soligenix has been…

7 days ago